Clinical Trials Browser

Completed × Interventional × Sexually Transmitted Diseases × Clear all

Condylomata Acuminata, Sexually Transmitted Diseases, Skin Diseases, Skin Diseases, Infectious, Virus Diseases, Warts, Sexually Transmitted Diseases, Viral, Skin Diseases, Viral, Papillomavirus Infections

NCT02482428 2021-01-05

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

Phase 2 Completed

88 enrolled 10 charts

Condylomata Acuminata, Sexually Transmitted Diseases, Virus Diseases, Papillomavirus Infections

NCT02572401 2019-10-15

STAND

Phase NA Completed

391 enrolled 15 charts

Endocrine

Acquired Immunodeficiency Syndrome, Sexual Behavior, Sexually Transmitted Diseases, Multiple Endocrine Neoplasia Type 1

NCT02724254 2018-07-20

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients

Phase 2 Completed

218 enrolled

Condylomata Acuminata, Sexually Transmitted Diseases, Virus Diseases, Papillomavirus Infections

NCT02535104 2018-06-06

Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)

Phase 1/2 Completed

70 enrolled

Condylomata Acuminata, Sexually Transmitted Diseases, Papillomavirus Infections

NCT01490359 2017-12-19

Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men

Phase NA Completed

1,181 enrolled 17 charts

Endocrine

Acquired Immunodeficiency Syndrome, Sexually Transmitted Diseases, Multiple Endocrine Neoplasia Type 1

NCT00849823 2017-07-14

HIV Prevention Program for African American Teen Males

Phase NA Completed

840 enrolled

Endocrine

Sexually Transmitted Diseases, HIV Infections, Multiple Endocrine Neoplasia Type 1

NCT00314028 2013-12-16

Effectiveness of HIV Risk Reduction Program Among African American Men

Phase 3 Completed

270 enrolled

Endocrine

Sexually Transmitted Diseases, Multiple Endocrine Neoplasia Type 1

Clinical Trials

CARE-1

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

STAND

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients

Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)

Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men

HIV Prevention Program for African American Teen Males

Effectiveness of HIV Risk Reduction Program Among African American Men